Skip to main content

Table 1 Details of patients recruited for study

From: Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis

Patient ID

Age

Gender

Condition

Duration (yrs)a

1

73

F

OA

12

2

69

F

OA

15

3

74

M

OA

2

4

71

F

OA

3

5

68

F

OA

4

6

61

F

OA

1

7

72

F

OA

3

8

75

F

OA

8

9

66

F

OA

1.5

10

59

F

OA

5

11

51

M

Post-traumatic OA

6

12

89

M

OA

4

13

78

M

OA

1

14

57

F

AVN, secondary OA

8

15

73

F

OA

3

16

59

M

OA

6

17

87

F

OA

1.5

18

89

F

OA

7

19

77

M

OA

1.5

20

77

F

OA

4

21

78

M

OA

5

22

71

F

OA

3

23

71

M

OA

1.5

24

46

F

AVN, secondary OA

4

25

50

F

RA

5.5

26

74

M

OA

1.5

27

69

M

OA

25

28

83

F

OA

3

29

89

F

OA

11

30

72

F

OA second knee

13

31

80

F

OA

20

32

77

M

OA

5

33

71

F

OA

11

34

95

F

OA

3

  1. OA osteoarthritis, RA rheumatoid arthritis, AVN avascular necrosis
  2. aDuration is the time in years between first report of disease symptoms and surgery, for each patient